ロード中...
Aspirin Reduces the Potentiating Effect of CD40L on Platelet Aggregation via Inhibition of Myosin Light Chain
BACKGROUND: Antiplatelet therapy with aspirin (acetylsalicylic acid [ASA]) is less efficient in some coronary patients, which increases their risk of developing thrombosis. Elevated blood levels of thromboinflammatory mediators, like soluble CD40L (sCD40L), may explain such variabilities. We hypothe...
保存先:
| 出版年: | J Am Heart Assoc |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7033871/ https://ncbi.nlm.nih.gov/pubmed/32009527 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.119.013396 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|